Suppressing Neuroinflammation: T-REG Cell Therapy of ALS

Time: 5:00 pm
day: Day One


  • Analyzing T-regs dysfunctional in neurodegenerative diseases to aid future therapeutic development
  • Understanding how ex vivo expansion restores T-Reg suppressive function to highlight neuroprotective factors that may arise from targeting neuroinflammation
  • Using clinical trial data to highlight how autologous T-reg infusions slow disease progression to thus suggest a potential avenue towards curing neurodegenerative diseases